| |
|
|
|
La Jolla Pharmaceutical Company  
|
|
7.15 -0.02 (-0%) |
04-18 16:00 |
|
Open: |
7.15 |
Pre close: |
7.17 |
Target:
|
9.13
|
|
High: |
7.27 |
Low: |
7.075 |
Resistance:
|
7.82
9.13
|
|
Volume: |
175,022 |
Market Cap: |
194M |
Support:
|
6.89
6.31
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.21
 |
MACD |
MACD(12,26):
|
0.12  |
|
MA(20): |
6.97 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
8.16 |
Stochastic Oscillator |
%K(14,3):
|
73.58 |
|
MA(250): |
18.43 |
%D(3): |
76.49 |
|
Average Volume(K) |
3-Month: |
60927
|
52-Week |
High:
|
38.39 |
|
10-Days: |
29477 |
Low: |
5.01 |
|
RSI |
RSI(14):
|
53.45 |
Change(%): |
-76.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.900 |
Return on Equity (ttm) |
-359.9 |
Shares Out. (M) |
27.08 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-123.2 |
Shares Float (M) |
25.48 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
-0.12 |
% Held by Insiders |
6.10 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
168.10 |
|
Forward EPS |
-2.611 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
6.470 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-152.37 |
P/S |
484055008.00 |
|
Operating Margin |
-1881.97 |
Levered Free Cash Flow
(M) |
-79.11 |
P/CF |
-1.27 |
|
|
|
|
|
|
